Vol 94, No 6 (2023)
Clinical vignette
Published online: 2022-08-11

open access

Page views 1644
Article views/downloads 559
Get Citation

Connect on Social Media

Connect on Social Media

Advanced ovarian cancer imitating deep infiltrating endometriosis. Radical resection and reconstructive surgery of the anterior abdominal wall

Patrycja Stec1, Anna Rygula1, Marcin Jedryka23, Rafal Matkowski24, Piotr Lepka23
Pubmed: 35984343
Ginekol Pol 2023;94(6):507-508.


Endometriosis is a disease affecting approximately 10–15% of the female population of reproductive age [1]. A rare location is endometriosis in the scar after caesarean section — CSE (caesarean scar endometriosis) accounting for 0.5–1.0 % of all cases. Although endometriosis is usually a benign condition, its malignant transformation affects 0.7–1% of cases. In women diagnosed with ovarian cancer, foci of endometriosis are present in up to 30% of patients. This paper presents the case of a 36-year-old patient initially diagnosed with extensive endometriosis involving the anterior abdominal wall and the pelvis minor. After biopsy, a diagnosis of advanced low-grade serous ovarian cancer was established. The diagnostic methods used and the extent of surgery with reconstruction of the anterior abdominal wall were described.

Article available in PDF format

View PDF Download PDF file


  1. Mehedintu C, Plotogea MM, Ionescu S, et al. Endometriosis still a challenge. J Med Life. 2014; 15(7): 349–357.
  2. Kobayashi H, Sumimoto K, Moniwa N. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan . Int J Gynecol Cancer. 2007; 17(1): 37–43.
  3. Ijichi S, Mori T, Suganuma I, et al. Clear cell carcinoma arising from cesarean section scar endometriosis: case report and review of the literature. Case Rep Obstet Gynecol. 2014; 2014: 642483.
  4. Krawczyk N, Banys-Paluchowski M, Schmidt D, et al. Endometriosis-associated Malignancy. Geburtshilfe Frauenheilkd. 2016; 76(2): 176–181.
  5. Grabowski JP, Harter P, Heitz F, et al. Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase. Gynecol Oncol. 2016; 140(3): 457–462.